JP2018526985A5 - - Google Patents

Download PDF

Info

Publication number
JP2018526985A5
JP2018526985A5 JP2018504233A JP2018504233A JP2018526985A5 JP 2018526985 A5 JP2018526985 A5 JP 2018526985A5 JP 2018504233 A JP2018504233 A JP 2018504233A JP 2018504233 A JP2018504233 A JP 2018504233A JP 2018526985 A5 JP2018526985 A5 JP 2018526985A5
Authority
JP
Japan
Prior art keywords
keratinocytes
expression
activity
activation
measured
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018504233A
Other languages
English (en)
Japanese (ja)
Other versions
JP6678231B2 (ja
JP2018526985A (ja
Filing date
Publication date
Priority claimed from EP15306219.5A external-priority patent/EP3124620B1/en
Application filed filed Critical
Publication of JP2018526985A publication Critical patent/JP2018526985A/ja
Publication of JP2018526985A5 publication Critical patent/JP2018526985A5/ja
Application granted granted Critical
Publication of JP6678231B2 publication Critical patent/JP6678231B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018504233A 2015-07-27 2016-07-26 皮膚バリア機能を改善するため、ならびに／または皮膚の老化を予防および／もしくは軽減するため、ならびに／または皮膚を保湿するのに使用するためのｕｃ．２９１の活性化因子 Active JP6678231B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15306219.5A EP3124620B1 (en) 2015-07-27 2015-07-27 Activators of uc.291 for use for improving skin barrier function and/or for preventing and/or attenuating skin ageing and/or for hydrating skin
EP15306219.5 2015-07-27
PCT/EP2016/067784 WO2017017094A1 (en) 2015-07-27 2016-07-26 Activators of uc.291 for use for improving skin barrier function and/or for preventing and/or attenuating skin ageing and/or for hydrating skin

Publications (3)

Publication Number Publication Date
JP2018526985A JP2018526985A (ja) 2018-09-20
JP2018526985A5 true JP2018526985A5 (enExample) 2018-11-01
JP6678231B2 JP6678231B2 (ja) 2020-04-08

Family

ID=53776527

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018504233A Active JP6678231B2 (ja) 2015-07-27 2016-07-26 皮膚バリア機能を改善するため、ならびに／または皮膚の老化を予防および／もしくは軽減するため、ならびに／または皮膚を保湿するのに使用するためのｕｃ．２９１の活性化因子

Country Status (4)

Country Link
US (1) US20180216182A1 (enExample)
EP (1) EP3124620B1 (enExample)
JP (1) JP6678231B2 (enExample)
WO (1) WO2017017094A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023069413A (ja) * 2021-11-05 2023-05-18 花王株式会社 被膜の皮膚保湿効果の評価方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ299379A (en) * 1995-10-27 1997-04-24 Unilever Plc Topical flavanone-containing composition
JP2005530708A (ja) 2002-03-20 2005-10-13 エナマニィ，ラスィド フィトアレキシンの製造方法
JP6043343B2 (ja) * 2011-05-17 2016-12-14 シャネル パフュームズ ビューテ 皮膚の老化の予防および／もしくは低減ならびに／または皮膚を水和するためのｌａｒｇｅ、ｈｓ６ｓｔ２またはｓｔ８ｓｉａ１活性化剤
FR2987371B1 (fr) * 2012-02-24 2016-01-01 Isp Investments Inc Methode d'identification in vitro de composes modulateurs de la differenciation cellulaire par dosage du micro-arn mir-203
JP6190105B2 (ja) * 2012-11-13 2017-08-30 株式会社ナリス化粧品 皮膚バリア機能改善剤のスクリーニング方法
US9981913B2 (en) * 2013-09-04 2018-05-29 Ralexar Therapeutics, Inc. Liver X receptor (LXR) modulators

Similar Documents

Publication Publication Date Title
BR112015022934A2 (pt) esteroides neuroativos, composições, e uso do mesmo
BR112015007625A2 (pt) aparelho, método de geração de uma medida de interferência de áudio e produto de programa de computador
MX365944B (es) Aparato y metodo para colorear pelo personalizado.
Stoddart et al. In vitro experiments with primary mammalian cells: to pool or not to pool
BR112015019453A2 (pt) método, dispositivo e conjunto para a avaliação da qualidade de uma amostra biológica e uso de pelo menos um biorrotulador
WO2014174114A3 (en) Hair dyeing process using henna and then indigo and an oil and/or butter
BR112014026568A2 (pt) método e aparelho para projeto de componentes de oleoduto
WO2015123192A3 (en) Universal system, method and solution for the acceleration of the process of fixing, dehydrating and clearing the structure of biological tissue
BR112014012003A2 (pt) sistema de controle de qualidade, método e meio legível por computador para o uso com bens de consumo, usuários e dispositivos de teste de diagnóstico biológico/ambiental
MX376501B (es) Adn huésped como biomarcador de la enfermedad de crohn.
JP2013099305A5 (enExample)
JP2018526985A5 (enExample)
MX2023006660A (es) Composiciones, dispositivos, y metodos de pruebas de sensibilidad a la osteoartritis.
WO2015086727A3 (en) New prognostic method for patients suffering of a cancer
BR112016004001B8 (pt) método para a avaliação do efeito potencial in vivo da proteção de cor
BR112016015977A2 (pt) Uso de giberelina 7, e, métodos para desbastar e cultivar drupas
EP4391861A4 (en) DEVICE, COMPONENTS AND KITS FOR THE APPLICATION OF HAIR COMPOSITIONS AND THEIR MANUFACTURE AND USE
BR112019003709A2 (pt) nanopartículas de silício multifuncionalizadas, usos de nanopartículas de silício multifuncionalizadas, composição e métodos para medir um analito por um método in vitro
SG11201806045XA (en) Mobilization of pluripotent stem cells for ischemic cerebral infarction
JP2014048235A5 (enExample)
BR112013020681A2 (pt) método para melhorar a qualidade e funcionalidade de papel de filtro apropriado para coleta de amostras biológicas
Innocent et al. Relative Significance of Waist Circumference, Body Mass Index and Waist-Hip Ratio as Predictors of the Metabolic Syndrome in an Apparently Healthy Nigerian Population
Jin et al. Nonadditivity in loglinear models using ϕ-divergences and MϕEs under product-multinomial sampling
JP2014028787A5 (enExample)
RU2017144058A (ru) Способ оценки безопасности химической продукции для здоровья человека